CN1198625C - 用于治疗粘膜炎、口炎和贝赫切特综合征的药物组合物 - Google Patents

用于治疗粘膜炎、口炎和贝赫切特综合征的药物组合物 Download PDF

Info

Publication number
CN1198625C
CN1198625C CNB018134386A CN01813438A CN1198625C CN 1198625 C CN1198625 C CN 1198625C CN B018134386 A CNB018134386 A CN B018134386A CN 01813438 A CN01813438 A CN 01813438A CN 1198625 C CN1198625 C CN 1198625C
Authority
CN
China
Prior art keywords
composition
mucositis
sodium
stomatitis
excipients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB018134386A
Other languages
English (en)
Chinese (zh)
Other versions
CN1474700A (zh
Inventor
M·马斯特罗多纳托
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Pharmaceutical Co Ltd
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of CN1474700A publication Critical patent/CN1474700A/zh
Application granted granted Critical
Publication of CN1198625C publication Critical patent/CN1198625C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
CNB018134386A 2000-07-28 2001-07-18 用于治疗粘膜炎、口炎和贝赫切特综合征的药物组合物 Expired - Lifetime CN1198625C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001732A IT1318649B1 (it) 2000-07-28 2000-07-28 Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
ITMI2000A001732 2000-07-28

Publications (2)

Publication Number Publication Date
CN1474700A CN1474700A (zh) 2004-02-11
CN1198625C true CN1198625C (zh) 2005-04-27

Family

ID=11445589

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018134386A Expired - Lifetime CN1198625C (zh) 2000-07-28 2001-07-18 用于治疗粘膜炎、口炎和贝赫切特综合征的药物组合物

Country Status (25)

Country Link
US (1) US20020173485A1 (enExample)
EP (1) EP1313489B1 (enExample)
JP (1) JP2004505028A (enExample)
KR (1) KR100761051B1 (enExample)
CN (1) CN1198625C (enExample)
AR (1) AR030068A1 (enExample)
AT (1) ATE289512T1 (enExample)
AU (2) AU1211302A (enExample)
BR (1) BRPI0112962B8 (enExample)
CA (1) CA2424346C (enExample)
CZ (1) CZ301461B6 (enExample)
DE (1) DE60109044T2 (enExample)
ES (1) ES2236324T3 (enExample)
HR (1) HRP20030046B1 (enExample)
IT (1) IT1318649B1 (enExample)
MX (1) MXPA03000712A (enExample)
MY (1) MY130477A (enExample)
NO (1) NO329574B1 (enExample)
NZ (1) NZ523832A (enExample)
PL (1) PL204397B1 (enExample)
PT (1) PT1313489E (enExample)
RU (1) RU2272636C2 (enExample)
UA (1) UA79075C2 (enExample)
WO (1) WO2002009637A2 (enExample)
ZA (1) ZA200300712B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109328058A (zh) * 2016-07-27 2019-02-12 株式会社利他药业 口腔粘膜贴附材料及其制造方法

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
PT1997478E (pt) 2001-02-15 2013-12-10 Access Pharma Inc Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
KR100518152B1 (ko) 2002-05-09 2005-09-29 메디제네스(주) 혈장 또는 혈청을 함유한 창상 치료용 약학 조성물
WO2004064850A1 (en) * 2003-01-23 2004-08-05 Ml Laboratories Plc Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent
GB0312485D0 (en) * 2003-05-30 2003-07-09 Dodson & Horrell Horse food composition
ITMI20031291A1 (it) 2003-06-25 2004-12-26 Ricerfarma Srl Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
CA2537080A1 (en) * 2003-08-21 2005-03-31 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8377468B2 (en) 2006-08-28 2013-02-19 Rexaderm, Inc. Dry wound dressing and drug delivery system
KR100758636B1 (ko) * 2006-12-19 2007-09-13 고려대학교 산학협력단 생체 점막 점착성 고분자 접합체 및 이의 제조방법
US20090123390A1 (en) 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
AU2008321395B2 (en) 2007-11-13 2013-03-14 Viropharma Biologics Llc Corticosteroid compositions
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
GB0813589D0 (en) * 2008-07-24 2008-09-03 Sinclair Pharmaceuticals Ltd Composition
ES2428337T3 (es) * 2009-05-25 2013-11-07 Sofar Swiss Sa Uso de una combinación fija de glucosaminoglucanos y composición masticable que comprende dicha combinación fija
CA2796346C (en) 2010-04-14 2018-10-02 Altria Client Services Inc. Preformed smokeless tobacco product
US9622962B2 (en) 2010-11-12 2017-04-18 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
ITMI20110954A1 (it) * 2011-05-26 2012-11-27 Professional Dietetics Srl Combinazioni per il trattamento delle mucositi vaginali o rettali
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
RU2693384C2 (ru) * 2013-10-16 2019-07-02 Квест Продактс, ЛЛС Лечение повреждений слизистой оболочки с использованием гиалуронана, доставляемого из приклеивающейся пастилки
CN105342987A (zh) * 2015-12-04 2016-02-24 亚飞（上海）生物医药科技有限公司 一种凝胶及其制备方法和应用
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
CN106176863A (zh) * 2016-08-04 2016-12-07 陈广圣 一种医用抗菌剂
CN107802641A (zh) * 2016-09-09 2018-03-16 李明典 口腔软组织(牙龈、粘膜)抗发炎酸痛剂
EP3459368B1 (en) * 2017-09-20 2025-08-20 Geophyt S.r.L. Food integrator for antineoplastic therapies
CN109331023A (zh) * 2018-11-12 2019-02-15 沈阳药科大学 甘草次酸的医药用途
KR102475125B1 (ko) 2019-08-07 2022-12-07 고려대학교 산학협력단 일산화질소 복합체를 포함하는 구강 점막염 치료용 조성물 및 구강 점막염 치료제
EP4048237B1 (en) * 2019-10-25 2024-02-28 Mucocort AB Treatment of inflammatory condition in mucous membrane or skin with low amounts of propylene glycol
IT202100011879A1 (it) * 2021-05-10 2022-11-10 Aurora Biofarma S R L Composizione orale per il trattamento delle esofagiti
CN116370333A (zh) * 2021-12-24 2023-07-04 太阳星光齿磨公司 含β-甘草次酸的组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092442B (en) * 1981-02-06 1984-02-08 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity containing glycyrrhetinic acid or a derivative thereof
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
JPS6117510A (ja) * 1984-07-03 1986-01-25 Toyobo Co Ltd 口腔粘膜適用徐放性ニフエジピン製剤
JPS6440423A (en) * 1987-08-05 1989-02-10 Kyukyu Yakuhin Kogyo Kk Patch for mucosa in oral cavity
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
FR2720937B1 (fr) * 1994-06-08 1997-03-28 Oreal Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
JPH09169652A (ja) * 1995-12-18 1997-06-30 Lion Corp 水性液状組成物
JPH10182390A (ja) * 1996-12-25 1998-07-07 Lion Corp 口腔用組成物
JP2000178185A (ja) * 1998-12-18 2000-06-27 Lion Corp 口腔粘膜付着型徐放性錠剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109328058A (zh) * 2016-07-27 2019-02-12 株式会社利他药业 口腔粘膜贴附材料及其制造方法

Also Published As

Publication number Publication date
NO329574B1 (no) 2010-11-15
WO2002009637A2 (en) 2002-02-07
EP1313489B1 (en) 2005-02-23
WO2002009637A3 (en) 2002-12-05
PL362921A1 (en) 2004-11-02
NO20030411D0 (no) 2003-01-27
AU2002212113B2 (en) 2006-01-12
PT1313489E (pt) 2005-05-31
CA2424346C (en) 2010-03-09
US20020173485A1 (en) 2002-11-21
MY130477A (en) 2007-06-29
BRPI0112962B8 (pt) 2021-05-25
AU1211302A (en) 2002-02-13
ATE289512T1 (de) 2005-03-15
NZ523832A (en) 2003-09-26
ITMI20001732A1 (it) 2002-01-28
PL204397B1 (pl) 2010-01-29
CA2424346A1 (en) 2002-02-07
CN1474700A (zh) 2004-02-11
ZA200300712B (en) 2004-02-09
AR030068A1 (es) 2003-08-13
HK1059215A1 (en) 2004-06-25
KR20030069979A (ko) 2003-08-27
EP1313489A2 (en) 2003-05-28
NO20030411L (no) 2003-01-27
BR0112962B1 (pt) 2013-12-31
KR100761051B1 (ko) 2007-10-04
IT1318649B1 (it) 2003-08-27
CZ301461B6 (cs) 2010-03-10
BR0112962A (pt) 2003-06-24
JP2004505028A (ja) 2004-02-19
HRP20030046A2 (en) 2004-04-30
HRP20030046B1 (hr) 2011-08-31
MXPA03000712A (es) 2004-11-01
DE60109044D1 (de) 2005-03-31
DE60109044T2 (de) 2005-07-21
ES2236324T3 (es) 2005-07-16
UA79075C2 (uk) 2007-05-25
ITMI20001732A0 (it) 2000-07-28
RU2272636C2 (ru) 2006-03-27

Similar Documents

Publication Publication Date Title
CN1198625C (zh) 用于治疗粘膜炎、口炎和贝赫切特综合征的药物组合物
US6828308B2 (en) Compositions and methods for the treatment or prevention of inflammation
AU2002212113A1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
US4748022A (en) Topical composition
EP2037941B1 (en) Cobalamin compositions for treating or preventing mucositis
RU2003101393A (ru) Фармацевтические композиции для лечения воспаления слизистой оболочки, стоматита и синдрома бехчета
WO2019155389A1 (en) An aqueous mucoadhesive and bioadhesive composition for the treatment
HU228669B1 (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome
CN1128614C (zh) 二氯苄醇在制备局部治疗炎症的制剂中的应用和含它的制剂
US8236814B2 (en) Composition and method for treatment of warts
JP2025532421A (ja) 潰瘍を予防及び又は治療するためのスチルベン誘導体の使用
HK1059215B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
TWI252103B (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and Behcet's syndrome
WO2004000253A1 (en) Improved pharmaceutical dental formulations
AU2004222773A1 (en) A method for treatment of mouth lesions
HK1027036B (en) Topical pharmaceutical compositions for wound healing
HK1027036A1 (en) Topical pharmaceutical compositions for wound healing
HK1073603A (en) Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1059215

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20170502

Address after: Wiltshire

Patentee after: United Pharmaceutical Co Ltd

Address before: British Godel Ming

Patentee before: Sinclair Pharmaceuticals Ltd.

TR01 Transfer of patent right
CX01 Expiry of patent term

Granted publication date: 20050427

CX01 Expiry of patent term